These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8862045)

  • 21. Abortive foveal retinal neovascularization in diabetic retinopathy.
    Finkelstein D; Patz A; Fine SL; Rice TA; Murphy RP
    Retina; 1981; 1(1):62-6. PubMed ID: 15633408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Development of neovascularization of the optic papilla, retina and iris. Dependence on site and extent of retinal ischemia].
    Nahberger D; Meyer-Schwickerath R; Saygili O; Gronemeyer U
    Ophthalmologe; 2000 Jun; 97(6):422-8. PubMed ID: 10916386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diabetic papillopathy in type II diabetic patients.
    Bayraktar Z; Alacali N; Bayraktar S
    Retina; 2002 Dec; 22(6):752-8. PubMed ID: 12476102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of growth factors in proliferative diabetic retinopathy.
    Forrester JV; Shafiee A; Schröder S; Knott R; McIntosh L
    Eye (Lond); 1993; 7 ( Pt 2)():276-87. PubMed ID: 7607347
    [No Abstract]   [Full Text] [Related]  

  • 25. Different determinants of neovascularization on the optic disc and on the retina in patients with severe nonproliferative diabetic retinopathy.
    Valsania P; Warram JH; Rand LI; Krolewski AS
    Arch Ophthalmol; 1993 Feb; 111(2):202-6. PubMed ID: 7679270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Venous beading in two or more quadrants might not be a sensitive grading criterion for severe nonproliferative diabetic retinopathy.
    Chen L; Zhang X; Wen F
    Graefes Arch Clin Exp Ophthalmol; 2018 Jun; 256(6):1059-1065. PubMed ID: 29626228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy.
    Avery RL; Pearlman J; Pieramici DJ; Rabena MD; Castellarin AA; Nasir MA; Giust MJ; Wendel R; Patel A
    Ophthalmology; 2006 Oct; 113(10):1695.e1-15. PubMed ID: 17011951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retinal Oximetry Differences Between Optic Disc Collateral Vessels and New Vessels.
    Nicholson L; Sivapathasuntharam C; Zola M; Hykin P; Bainbridge JW; Sivaprasad S
    JAMA Ophthalmol; 2017 Sep; 135(9):1003-1004. PubMed ID: 28772311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetic papillopathy and proliferative retinopathy.
    Stransky TJ
    Graefes Arch Clin Exp Ophthalmol; 1986; 224(1):46-50. PubMed ID: 2417914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SYSTEMIC INTERLEUKIN 1β INHIBITION IN PROLIFERATIVE DIABETIC RETINOPATHY: A Prospective Open-Label Study Using Canakinumab.
    Stahel M; Becker M; Graf N; Michels S
    Retina; 2016 Feb; 36(2):385-91. PubMed ID: 26218500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Functional diagnostics of retinal ischemia: Muller cells and neovascularization of the retina in diabetic retinopathy].
    Neroev VV; Zueva MV; Tsapenko IV; Riabina MV; Hun L
    Vestn Oftalmol; 2005; 121(1):22-4. PubMed ID: 15759843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals.
    Adamis AP; Altaweel M; Bressler NM; Cunningham ET; Davis MD; Goldbaum M; Gonzales C; Guyer DR; Barrett K; Patel M;
    Ophthalmology; 2006 Jan; 113(1):23-8. PubMed ID: 16343627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neodymium:YLF picosecond laser segmentation for retinal traction associated with proliferative diabetic retinopathy.
    Cohen BZ; Wald KJ; Toyama K
    Am J Ophthalmol; 1997 Apr; 123(4):515-23. PubMed ID: 9124248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The diagnostic value of the oscillatory potentials of the ERG and fluorescein angiography in diabetic proliferative retinopathy.
    Algvere P; Gjötterberg M
    Ophthalmologica; 1974; 168(2):97-108. PubMed ID: 4842096
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison between wide-angle OCT angiography and ultra-wide field fluorescein angiography for detecting non-perfusion areas and retinal neovascularization in eyes with diabetic retinopathy.
    Sawada O; Ichiyama Y; Obata S; Ito Y; Kakinoki M; Sawada T; Saishin Y; Ohji M
    Graefes Arch Clin Exp Ophthalmol; 2018 Jul; 256(7):1275-1280. PubMed ID: 29713816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Localized retinal morphology and differential light sensitivity in diabetic retinopathy. Methodology and clinical results.
    Bek T
    Acta Ophthalmol Suppl (1985); 1992; (207):1-36. PubMed ID: 1486330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A case of diabetic retinopathy with both retinal neovascularization and complete posterior vitreous detachment.
    Shiraya T; Kato S; Fukushima H; Tanabe T
    Eur J Ophthalmol; 2006; 16(4):644-6. PubMed ID: 16952113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topographical distribution of retinal and optic disc neovascularization in early stages of proliferative diabetic retinopathy.
    Jansson RW; Frøystein T; Krohn J
    Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8246-52. PubMed ID: 23169887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The results of intravitreal bevacizumab injections for persistent neovascularizations in proliferative diabetic retinopathy after photocoagulation therapy.
    Erdol H; Turk A; Akyol N; Imamoglu HI
    Retina; 2010 Apr; 30(4):570-7. PubMed ID: 20224478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unilateral proliferative diabetic retinopathy and uveitis in the fellow eye: report of a case.
    Scialdone A; Menchini U; Pietroni C; Brancato R
    Ann Ophthalmol; 1991 Jul; 23(7):259-61. PubMed ID: 1929093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.